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Cesarean sectionAbstract Background: Adding intrathecal opioids to intrathecal local anesthetics to decrease their
doses and provide hemodynamic stability are major goals during spinal anesthesia in cesarean sec-
tion. Different opioids were used to select the one with the longest duration of analgesia and the
least side effects. In this study, intrathecal nalbuphine was compared with intrathecal fentanyl as
an adjuvant to hyperbaric bupivacaine in cesarean section.
Patients and methods: Sixty female patients of ASA grades I and II presented for elective cesarean
deliveries with spinal anesthesia were randomly allocated to 2 equal groups; Group F: 30 patients
received intrathecal injection of 2 ml of 0.5% hyperbaric bupivacaine plus 0.5 ml fentanyl (25 lg);
Group N: 30 patients received intrathecal injection of 2 ml of 0.5% hyperbaric bupivacaine plus
0.5 ml nalbuphine (0.8 mg). The onset of sensory and complete motor blockade, time of sensory
blockade, duration of analgesia and motor blockade, fetal Apgar score, visual analog scale score,
oxygen saturation, adverse effects and hemodynamic parameters were recorded intra-operatively
and up to 4 h post-operatively. The effective analgesic time was recorded.
Results: The onset of complete motor block was signiﬁcantly more rapid in fentanyl group than in
nalbuphine group. The duration of post-operative analgesia was more prolonged in nalbuphine
group but the difference was insigniﬁcant. No signiﬁcant difference was found between both groups
as regards the duration of sensory block, motor block, duration of analgesia, fetal Apgar score,
visual analog scale score, hemodynamic parameters and oxygen saturation. Adverse effects were
less common in nalbuphine group but the difference was insigniﬁcant.
406 H.M. Gomaa et al.Conclusion: Either intrathecal nalbuphine 0.8 mg or intrathecal fentanyl 25 lg combined with 10 mg
bupivacaine provides good intra-operative and early post-operative analgesia in cesarean section.
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Spinal anesthesia for cesarean delivery is the best anesthetic
technique as it is simple to perform with rapid onset of anes-
thesia and complete muscle relaxation. Lower incidence of
failed block, less drug doses, minimal neonatal depression
and decreased incidence of aspiration pneumonitis are added
advantages of spinal anesthesia [1,2].
Intrathecal opioids are synergistic with local anesthetics
and intensify the sensory block without increasing the sympa-
thetic block. They are commonly added to local anesthetics for
potentiating their effects, reducing their doses, and thereby
reducing their complications and side effects and offer hemo-
dynamic stability. They also prolong the duration of post-
operative analgesia [3].
Fentanyl is a lipophilic opioid with a rapid onset following
intrathecal injection. It does not migrate to the 4th ventricle in
sufﬁcient concentration to cause respiratory depression. It is
commonly added to intrathecal bupivacaine in cesarean delivery
by many anesthesiologists [2,4–8]. It improves quality of anes-
thesia without producing signiﬁcant side effects and improves
post-operative analgesia and hemodynamic stability [9].
Nalbuphine, a mixed agonist–antagonist opioid, has a
potential to attenuate the mu-opioid effects and to enhance
the kappa-opioid effects. It was synthesized in an attempt to
produce analgesia without the undesirable side effects of a l
agonist. Also, its combination with l agonist opioids was tried
by many researchers [10–12] to decrease the incidence and
severity of the common l-agonist side effects (respiratory
depression, undesirable sedation, pruritus, nausea, vomiting
and urinary retention). Meanwhile, the beneﬁts of both j
and l analgesia can be obtained.
Few studies had investigated intrathecal nalbuphine with
hyperbaric bupivacaine [13,14], and as far as we know, no
study had compared it with intrathecal fentanyl which is the
opioid in common practice added to hyperbaric bupivacaine
in cesarean section.
The aim of the work was to compare the intra-operative
and post-operative analgesic effect of intrathecal nalbuphine
and intrathecal fentanyl as an adjuvant to bupivacaine during
cesarean delivery.
2. Patients and methods
After approval of the Local Ethics Committee and patients’
informed written consent, sixty female patients presented to
Kasr Al-Ainy Hospital for elective cesarean deliveries with
spinal anesthesia were enrolled in the study.
2.1. Inclusion criteria
ASA physical status I or II with normal coagulation proﬁle,
age between 20 and 45 years, weight between 60 and 90 kg
and height between 160 and 180 cm were enrolled in the
study.2.2. Exclusion criteria
ASA III or IV, patient refusal, infection at the site of injection,
coagulopathy, anticoagulant medications, pre-existing neuro-
logical disease, uncooperative patients, cardiac or respiratory
system failure, allergy to local anesthetics.
The patients were divided randomly using computer gener-
ated number and concealed using sequentially numbered,
sealed opaque envelope technique into two equal groups (each
30 patients): Group F and Group N.
All patients were clinically assessed and routine preopera-
tive investigations were done: CBC, PT, PTT, INR, liver func-
tion tests, kidney function tests, fasting blood sugar and ECG.
Ranitidine 150 mg was administered orally before surgery.
The monitors (electrocardiography, non-invasive blood
pressure and pulse oximetry) were applied to the patient on
arrival to the operating room. A suitable peripheral vein was
cannulated and I.V. Ringer solution 10 ml/kg/15 min (preload)
was given to all patients before the procedure.
All patients were put in the sitting position with leaning for-
ward. Sterilization was done. Dural puncture was performed at
L4–L5 interspace or L3–L4 with a 25 gauge Quincke spinal
needle.
The patients were divided equally into two groups accord-
ing to the additive (fentanyl or nalbuphine), and all patients
were received the same amount of local anesthetic (2 ml
0.5% heavy bupivacaine).
2.3. Group F (fentanyl) n = 30
Thirty patients received intrathecal injection of 2 ml of 0.5%
hyperbaric bupivacaine plus 0.5 ml fentanyl (25 lg).
2.4. Group N (nalbuphine) n = 30
Thirty patients received intrathecal injection of 2 ml of 0.5%
hyperbaric bupivacaine plus 0.5 ml nalbuphine hydrochloride
(0.8 mg) (naluﬁn 20 mg in 1 ml ampoule, Amoun Pharmaceu-
tical Co., Cairo, Egypt).
Spinal injections were done by anesthesiologists who did
not participate in recording patients’ data. Both patients and
observers were blinded to the drugs given.
Then, the patients were placed in the supine position with a
wedge under the right hip to maintain left uterine displace-
ment. Elevation of the head by a pillow and oxygen mask
5 l/min was applied.
2.5. The following parameters were recorded intra-operatively
Continuous monitoring to the conscious level and oxygen sat-
uration. The level of sensory block (assessed by pin prick) and
motor block (assessed by Bromage scale; 0 = none, 1 = just
able to move the knee but not the hip, 2 = able to move the
foot only, 3 = unable to move the knee or foot) [15] were con-
tinuously recorded until skin incision. Surgery began when the
Figure 2 SBP (mmHg) of the two studied groups. There was no
signiﬁcant difference in systolic blood pressure between group F
and group N.
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were measured noninvasively every 5 min. Atropine
(0.01 mg/kg) was given if H.R. decreased below 60/min. Inter-
mittent doses of ephedrine 10 mg I.V. if the systolic arterial
blood pressure decreased by more than 20% below pre-anes-
thetic level or less than 100 mmHg.
Visual analog scale (VAS) was recorded [it ranges from 0
indicating no pain till 10 indicating severe intolerable pain with
variable degrees of ascending pain in between]. If VASP 4,
general anesthesia was given and the patient was excluded.
The neonatal Apgar score at 1 min after delivery was calcu-
lated by an attending pediatrician. Complications related to
spinal block or drug allergy (hypotension, bradycardia, pruri-
tus, nausea, vomiting, shivering, rash and bronchospasm) were
recorded and managed.
A urinary catheter was left in situ and removed 24 h later.
2.6. The following parameters were recorded post-operatively up
to the time of the ﬁrst analgesic dose
Continuous monitoring to the conscious level, respiratory rate
and oxygen saturation, sensory level and motor block were
assessed every 15 min till complete recovery. Heart rate and
noninvasive blood pressure were recorded after 2 and 4 h.
The duration of analgesia (from intrathecal injections to VAS
greater than 0) was recorded. The time of the ﬁrst analgesic
dose was recorded (effective analgesic time: from intrathecal
injection to VASP 4). NSAIDs (non-steroidal anti-inﬂamma-
tory drugs) were given for analgesia to all patients scoringP 4.
Any complication was recorded and managed as before. In
addition: for vomiting; metoclopramide 10 mg I.V. was given,
for pruritus; pheniramine maleate 45.5 mg I.V. was given. For
shivering; pethidine 20 mg I.V. Respiratory depression was
deﬁned as a respiratory rate of <10 breaths/min and hypoxia
was deﬁned as an oxygen saturation of <95%.Figure 1 Heart rate (beats/min) of the two studied groups. There
was no signiﬁcant difference in the heart rate between group F and
group N.
Figure 3 DBP (mmHg) of the two studied groups. There was no
signiﬁcant difference in diastolic blood pressure between group F
and group N.
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Figure 4 SPO2 (%) of the two studied groups. No signiﬁcant
difference was found in oxygen saturation between group F and
group N.
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Being the primary outcome, power analysis was based on the
difference in duration of analgesia between fentanyl and nal-
buphine groups provided that we studied 30 cases in each
arm. Our results showed that the mean ± SD of duration of
analgesia was 155.8 ± 31 min in fentanyl group, while it was
166.7 ± 14 min in Nalbuphine group. If the true mean differ-
ence in duration of analgesia between the 2 drugs was similar
to our calculated difference (11 min), we will be able to reject
the null hypothesis with 89.9% power. Student’s t test was
used in the analysis with type I error probability equals 0.05.
Calculations were done using PS Power and Sample Size Cal-
culations Software, version 3.0.11 for MS Windows (William
D. Dupont and Walton D. Vanderbilt, USA).
2.8. Statistical analysis
Results were expressed as means ± standard deviation of the
means (SD) or number (%). Comparison between different
parameters in the two studied groups was performed using
unpaired t test. Comparison between categorical data was per-
formed using Chi square test. The data were considered signif-
icant if p value was equal to or less than 0.05 and highly
signiﬁcant if p value < 0.01. Statistical analysis was performed
with the aid of the SPSS computer program (version 12
windows).
3. Results
Sixty patients completed the study.
3.1. Group F (n = 30)
Fentanyl is the additive to bupivacaine.
3.2. Group N (n = 30)
Nalbuphine is the additive to bupivacaine (see Figs. 1–4;
Tables 1–3).
4. Discussion
Regional anesthesia is now more popular than general anes-
thesia during cesarean delivery because of the increased mor-
tality rate associated with general anesthesia [16]. Excessive
high regional blocks and local anesthetics toxicity are the com-
monest causes of mortality associated with regional blocks. So,Table 1 Demographic data and duration of surgery of the
Characteristics Fentanyl (n= 30)
Age (yrs) 26.33 ± 6.08
Height (cm) 168.97 ± 5.22
Weight (kg) 78.83 ± 8.26
Duration of surgery (min) 53.00 ± 5.19
Data are expressed as means ± standard deviation.
NS = p> 0.05 = not signiﬁcant.
There was no statistically signiﬁcant difference among the two grreduction in the doses of local anesthetics, the use of new tech-
niques to avoid higher blocks and better management of local
anesthetic toxicity are the new goals for decreasing mortality
associated with regional anesthesia [2].
Intrathecal opioids cause segmental analgesia by binding to
opioid receptors in the dorsal horn of the spinal cord. They
prolong the duration of analgesia without affecting motor or
autonomic nervous function. Their combination with intrathe-
cal local anesthetics limits the regression of the sensory block
seen with local anesthetics alone. Respiratory depression is
the most serious side effect of intrathecal opioids while pruri-
tus is the commonest. Others include nausea, vomiting, urine
retention and sedation [17,18].
In this prospective randomized double blind study, the
post-operative analgesic requirements and the spinally medi-
ated analgesic effects of bupivacaine (hyperbaric) 0.5% in
combination with fentanyl (25 lg) or nalbuphine (0.8 mg) in
patients undergoing elective cesarean section were observed
and recorded.
As regards the onset and duration of sensory block, there
was no statistically signiﬁcant difference between group F
and group N.
The onset of complete motor block was more rapid with
fentanyl than nalbuphine and this was statistically signiﬁcant.
This may be explained by the high lipid solubility and rapid tis-
sue uptake of fentanyl more than nalbuphine, and this needs
further studies.
Also in the present study, no statistically signiﬁcant differ-
ence was found between both groups as regards the duration of
motor block, hemodynamics and oxygen saturation. Neither
bradycardia nor oxygen desaturation was recorded.
The duration of post-operative analgesia and the effective
analgesic time were more prolonged in nalbuphine group than
in fentanyl group with no statistically signiﬁcant difference.
As regards the side effects, they were less in nalbuphine
group than the fentanyl group with no statistically signiﬁcant
difference. The fetal Apgar score showed no statistically signif-
icant difference between both groups.
Intrathecal fentanyl is used commonly with heavy bupiva-
caine 0.5% for spinal and epidural anesthesia by many
researchers [2,4–7]. Kang et al. [7] combined it with heavy
bupivacaine during cesarean section to provide adequate depth
of anesthesia. The duration of complete analgesia was longer
in (bupivacaine and fentanyl) group 146 ± 47 min versus
bupivacaine alone 104 ± 44 min. The incidence of pruritus
was higher with fentanyl but shivering was less. This compar-
ison was also done by Biswas et al. [5] in cesarean section and
concluded the same results.
Sivevski [19] had studied the combination of reduced dose
of local anesthetics (9 mg of isobaric bupivacaine) withtwo studied groups.
Nalbuphine (n= 30) p Value
26.97 ± 5.40 0.671 (NS)
170.30 ± 6.94 0.404 (NS)
81.53 ± 9.85 0.255 (NS)
53.17 ± 4.82 0.898 (NS)
oups as regards: age, height, weight and duration of surgery.
Table 2 Sensory block, motor block and duration of analgesia of the two studied groups.
Characteristics Fentanyl (n= 30) Nalbuphine (n= 30) p Value
Onset of sensory block (min) 1.64 ± 0.09 1.60 ± 0.10 0.131 (NS)
Onset of complete motor block (min) 5.57 ± 0.23 5.72 ± 0.17 0.008**
2 Segment regression time of sensory block (min) 122.33 ± 5.21 123.00 ± 5.66 0.637 (NS)
Duration of motor block (min) 125.87 ± 20.17 125.33 ± 5.71 0.890 (NS)
Duration of analgesia (min) 155.83 ± 30.96 166.33 ± 14.02 0.096 (NS)
Eﬀective analgesic time (min) 222.5 ± 28.46 231.83 ± 15.73 0.1215(NS)
Data are expressed as means ± standard deviation.
NS = p> 0.05 = not signiﬁcant.
No statistically signiﬁcant difference was found between both groups as regards the onset of sensory block, 2 segment regression time of sensory
block and duration of motor block.
There was statistically signiﬁcant more rapid onset of complete motor block in group F than in group N.
The duration of analgesia and the effective analgesic time were more prolonged in group N than in group F but this was not statistically
signiﬁcant.
** p< 0.01 = highly signiﬁcant.
Table 3 Adverse effects and fetal Apgar score in the two studied groups.
Characteristics Fentanyl (n= 30) Nalbuphine (n= 30) p Value
Hypotension 8 (26.7%) 6 (20%) 0.542 (NS)
Neusea and vomiting 3 (10%) 1 (3.3%) 0.301 (NS)
Pruritus 1 (3.3%) 0 (0%) 0.313 (NS)
Shivering 2 (6.7%) 1 (3.3%) 0.554 (NS)
Fetal Apgar score 8.83 ± 0.46 8.83 ± 0.38 1.000 (NS)
Data are expressed as means ± standard deviation or number (%).
NS = p> 0.05 = not signiﬁcant.
The adverse effects were less in group N than group F but there was no signiﬁcant difference between both groups.
Respiratory rates were similar for both groups. Maternal oxygen saturation to <95% was not observed.
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doses of local anesthetics alone (13.5 mg of isobaric bupiva-
caine) during cesarean delivery. He concluded that adding
intrathecal opioids to reduced dose of local anesthetics can
produce adequate spinal anesthesia with minimum hypoten-
sion and decreased vasopressor requirements. Also, the
increased incidence of emesis with the use of bupivacaine alone
may be secondary to increased incidence of hypotension
because the emetic effects are relieved after the administration
of ephedrine and elevation of blood pressure.
Obara et al. [8] and Chavada et al. [9]agreed with these
results. They concluded that the addition of intrathecal fenta-
nyl to hyperbaric bupivacaine decreased the required amount
of intra-operative analgesics and improved quality of anesthe-
sia without producing signiﬁcant side effects.
The ﬁrst study which used intrathecal nalbuphine was con-
ducted by Culebras et al. [14] who compared intrathecal mor-
phine (0.2 mg) added to hyperbaric bupivacaine with different
doses of intrathecal nalbuphine (0.2 mg), (0.8 mg) and (1.6 mg)
added to hyperbaric bupivacaine in cesarean section and their
study concluded that intrathecal nalbuphine 0.8 mg provides
good intra-operative and early post-operative analgesia with-
out side effects (no PONV or pruritus). Nalbuphine 1.6 mg
did not increase efﬁcacy but increased the incidence of compli-
cations. So, the dose 0.8 mg was chosen in this study. They
also reported that the post-operative analgesia lasted signiﬁ-
cantly longer in the morphine group. There was no maternal
or newborn respiratory depression and the neonatal conditions
(Apgar scores and arterial blood gas values) were similar for
all groups.Regarding the appropriate dose of intrathecal nalbuphine,
Lin [20] had compared intrathecal nalbuphine 400 lg added
to hyperbaric tetracaine with intrathecal morphine 400 lg
and concluded that intrathecal nalbuphine in a dose of
400 lg prolongs intra-operative and post-operative analgesia
with fewer side effects. Culebras et al. [14] recommended the
dose of 0.8 mg nalbuphine to be injected intrathecally after
cesarean delivery and explained their difference with Lin [20]
by the fact that they used a different patient population
(non-pregnant patients) and different local anesthetic (hyper-
baric tetracaine).
Mukherjee et al. [21] had studied 100 patients undergoing
lower limb orthopedic surgery using subarachnoid block. They
used different doses of nalbuphine intrathecally (200, 400 and
800) lg added to 0.5% hyperbaric bupivacaine. They con-
cluded that the duration of sensory block and the duration
of effective analgesia were prolonged with the doses 400 lg
and 800 lg but the side effects were higher with the dose
800 lg.
Fournier et al. [22] compared between intrathecal nalbu-
phine 400 lg and intrathecal morphine 160 mcg in old patients
undergoing total hip replacement using continuous spinal
anesthesia. They concluded that intrathecal nalbuphine pro-
duces faster onset of pain relief but the duration of analgesia
is shorter than intrathecal morphine.
Yoon et al. [23] compared between intrathecal (morphine
0.1 mg), (nalbuphine 1 mg) and (morphine 0.1 mg with nalbu-
phine 1 mg) in addition to 0.5% bupivacaine 10 mg in 60
obstetric patients undergoing cesarean section. They con-
cluded that the duration of effective analgesia was longer with
410 H.M. Gomaa et al.morphine alone and morphine added to nalbuphine than in
nalbuphine group alone. The incidence of pruritus was signif-
icantly higher in morphine groups while nausea and vomiting
were the same in all groups.
Tiwari et al. [13] had compared intrathecal nalbuphine
200 lg and 400 lg added to hyperbaric bupivacaine with
bupivacaine alone. They concluded that the duration of sen-
sory block and duration of analgesia was maximally prolonged
with nalbuphine 400 lg without complications.
In a randomized, double blind, controlled study done by
Sapate et al. [24] on adding intrathecal nalbuphine to bupiva-
caine for patients undergoing infraumbilical surgeries, they
concluded that intrathecal nalbuphine added to bupivacaine
provides better quality of block and longer post-operative
analgesia (8–9) hours than bupivacaine alone without any sig-
niﬁcant adverse effects. This long duration can be explained by
doing the study in age group (50–70) years and by using higher
volume of heavy bupivacaine (3 ml).
As regards the neurotoxicity of intrathecal nalbuphine, it
has been used in modern practice for more than 10 years with-
out any reports of neurotoxicity [21].
5. Conclusion
We concluded that either intrathecal nalbuphine (0.8 mg) com-
bined with (10 mg) bupivacaine or intrathecal fentanyl (25 lg)
combined with (10 mg) bupivacaine improves intra-operative
analgesia and prolongs early post-operative analgesia in cesar-
ean section.
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